KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Entegris (ENTG) Research & Development (2016 - 2025)

Entegris has reported Research & Development over the past 16 years, most recently at $79.0 million for Q4 2025.

  • Quarterly results put Research & Development at $79.0 million for Q4 2025, down 3.07% from a year ago — trailing twelve months through Dec 2025 was $329.0 million (up 4.08% YoY), and the annual figure for FY2025 was $329.0 million, up 4.08%.
  • Research & Development for Q4 2025 was $79.0 million at Entegris, down from $80.9 million in the prior quarter.
  • Over the last five years, Research & Development for ENTG hit a ceiling of $84.8 million in Q1 2025 and a floor of $37.7 million in Q2 2021.
  • Median Research & Development over the past 5 years was $69.5 million (2022), compared with a mean of $66.0 million.
  • Biggest five-year swings in Research & Development: surged 54.84% in 2022 and later decreased 3.07% in 2025.
  • Entegris' Research & Development stood at $45.9 million in 2021, then soared by 48.11% to $68.0 million in 2022, then fell by 0.72% to $67.6 million in 2023, then grew by 20.64% to $81.5 million in 2024, then fell by 3.07% to $79.0 million in 2025.
  • The last three reported values for Research & Development were $79.0 million (Q4 2025), $80.9 million (Q3 2025), and $84.3 million (Q2 2025) per Business Quant data.